Balance sheet of Anthem Biosciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Anthem Biosciences is increasing.
Latest net debt of Anthem Biosciences is -₹465.78 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹525 Crs.

Yes, profit is increasing.
The profit of Anthem Biosciences is ₹554 Crs for TTM, ₹451 Crs for Mar 2025 and ₹367 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Anthem Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery